{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:29:32Z","timestamp":1759624172333,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ejogrb.2016.01.030","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T02:15:47Z","timestamp":1454897747000},"page":"141-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?"],"prefix":"10.1016","volume":"199","author":[{"given":"Belgin","family":"Devrano\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zkan","family":"\u00d6zdamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"K\u00f6le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem K.","family":"Eken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halenur","family":"Bozda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emek","family":"Do\u011fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2016.01.030_bib0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2009-0006","article-title":"Ovarian aging: mechanisms and clinical consequences","volume":"30","author":"Broekmans","year":"2009","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.ejogrb.2016.01.030_bib0190","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/35099086","article-title":"Commuting the death sentence: how oocytes strive to survive","volume":"2","author":"Tilly","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.ejogrb.2016.01.030_bib0195","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/80442","article-title":"Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1 phosphate therapy","volume":"6","author":"Morita","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0200","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/oxfordjournals.humrep.a137570","article-title":"Accelarated disappearance of ovarian follicles in mid-life: implications for forecasting menopause","volume":"7","author":"Faddy","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0205","first-page":"49","article-title":"Menstrual cyclicity and the perimenopause","volume":"19","author":"Treloar","year":"1981","journal-title":"Maturitas"},{"issue":"10","key":"10.1016\/j.ejogrb.2016.01.030_bib0210","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/09513590.2012.664192","article-title":"Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist","volume":"28","author":"Marci","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.01.030_bib0215","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0015-0282(01)02017-9","article-title":"Reproductive outcome in patients with diminished ovarian reserve","volume":"76","author":"Levi","year":"2001","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ejogrb.2016.01.030_bib0220","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/1933719112446074","article-title":"Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve","volume":"19","author":"Pastore","year":"2012","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2016.01.030_bib0225","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/humrep\/der431","article-title":"Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profiling","volume":"27","author":"May-Panloup","year":"2012","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.01.030_bib0230","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/gme.0b013e318193c48b","article-title":"Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging?","volume":"16","author":"Gleicher","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0015-0282(00)00625-7","article-title":"Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values?","volume":"74","author":"Trout","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0240","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0015-0282(00)00693-2","article-title":"Evaluation of basal estradiol levels in assisted reproductive technology cycles","volume":"74","author":"Frattarelli","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0245","first-page":"187","article-title":"Predicting poor ovarian response in IVF: use of repeat basal FSH measurement","volume":"49","author":"Bancsi","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/B:JARG.0000025936.73125.b4","article-title":"Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests","volume":"21","author":"Erdem","year":"2004","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0255","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0260","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"Van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antimullerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0270","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of anti-mullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0280","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","article-title":"Follicle stimulating hormone levels on cycle day 3 are predictive of an in vitro fertilization outcome","volume":"51","author":"Scott","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0285","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0015-0282(16)54249-6","article-title":"Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age","volume":"55","author":"Toner","year":"1991","journal-title":"Fertil Steril"},{"year":"2010","series-title":"WHO laboratory manual for the examination and processing of human semen","author":"World Health Organization","key":"10.1016\/j.ejogrb.2016.01.030_bib0290"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.01.030_bib0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0300","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/humrep\/deh827","article-title":"Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only in older but also in younger women in couples with idiopathic and male subfertility","volume":"20","author":"Goverde","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0305","first-page":"539","article-title":"A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population","volume":"82","author":"Scott","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.01.031","article-title":"Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation\/intrauterine insemination a good option?","volume":"211","author":"Souter","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0315","first-page":"2538","article-title":"Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization","volume":"86","author":"Dumesic","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.01.030_bib0320","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.fertnstert.2006.08.094","article-title":"Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization","volume":"87","author":"Luna","year":"2007","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.01.030_bib0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-6483(10)60957-1","article-title":"GnRH antagonist in IVF poor-responder patients: results of a randomized trial","volume":"11","author":"Marci","year":"2005","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.01.030_bib0330","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/09513590.2014.987228","article-title":"Poor responders in IVF: an update in therapy","volume":"31","author":"Giovanale","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0335","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(98)00079-X","article-title":"Young low responders protected from untoward effects of reduced ovarian response","volume":"69","author":"Hanoch","year":"1998","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2016.01.030_bib0340","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/humrep\/deh141","article-title":"An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve","volume":"19","author":"Abdalla","year":"2004","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2016.01.030_bib0345","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0015-0282(97)00531-1","article-title":"Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening","volume":"69","author":"Hofmann","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0350","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1210\/jc.2006-2399","article-title":"Predictive value and clinical impact of basal follicle-stimulating hormone in subfertile, ovulatory women","volume":"92","author":"Van der Steeg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0355","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1472-6483(10)60859-0","article-title":"Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility","volume":"12","author":"Van Rooij","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2016.01.030_bib0360","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/17.6.1519","article-title":"Young age does not protect against the adverse effects of reduced ovarian reserve \u2014 an eight year study","volume":"17","author":"El-Toukhy","year":"2002","journal-title":"Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516300094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516300094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:37:31Z","timestamp":1759556251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211516300094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":36,"alternative-id":["S0301211516300094"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.01.030","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}